PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
EQH vs. NVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between EQH and NVS is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

EQH vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Equitable Holdings, Inc. (EQH) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
24.16%
-10.30%
EQH
NVS

Key characteristics

Sharpe Ratio

EQH:

2.37

NVS:

-0.40

Sortino Ratio

EQH:

3.23

NVS:

-0.43

Omega Ratio

EQH:

1.43

NVS:

0.94

Calmar Ratio

EQH:

4.26

NVS:

-0.32

Martin Ratio

EQH:

15.46

NVS:

-0.75

Ulcer Index

EQH:

4.15%

NVS:

8.61%

Daily Std Dev

EQH:

27.07%

NVS:

16.26%

Max Drawdown

EQH:

-61.33%

NVS:

-41.72%

Current Drawdown

EQH:

0.00%

NVS:

-19.32%

Fundamentals

Market Cap

EQH:

$16.19B

NVS:

$198.53B

EPS

EQH:

-$0.91

NVS:

$5.72

Total Revenue (TTM)

EQH:

$8.82B

NVS:

$37.51B

Gross Profit (TTM)

EQH:

$4.34B

NVS:

$27.93B

EBITDA (TTM)

EQH:

$1.73B

NVS:

$15.56B

Returns By Period

In the year-to-date period, EQH achieves a 9.56% return, which is significantly higher than NVS's 0.23% return.


EQH

YTD

9.56%

1M

11.09%

6M

24.16%

1Y

60.15%

5Y*

18.24%

10Y*

N/A

NVS

YTD

0.23%

1M

0.43%

6M

-10.30%

1Y

-6.44%

5Y*

5.88%

10Y*

5.91%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EQH vs. NVS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EQH
The Risk-Adjusted Performance Rank of EQH is 9595
Overall Rank
The Sharpe Ratio Rank of EQH is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of EQH is 9393
Sortino Ratio Rank
The Omega Ratio Rank of EQH is 9292
Omega Ratio Rank
The Calmar Ratio Rank of EQH is 9797
Calmar Ratio Rank
The Martin Ratio Rank of EQH is 9696
Martin Ratio Rank

NVS
The Risk-Adjusted Performance Rank of NVS is 2525
Overall Rank
The Sharpe Ratio Rank of NVS is 2525
Sharpe Ratio Rank
The Sortino Ratio Rank of NVS is 2121
Sortino Ratio Rank
The Omega Ratio Rank of NVS is 2121
Omega Ratio Rank
The Calmar Ratio Rank of NVS is 2626
Calmar Ratio Rank
The Martin Ratio Rank of NVS is 3030
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EQH vs. NVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Equitable Holdings, Inc. (EQH) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for EQH, currently valued at 2.37, compared to the broader market-2.000.002.004.002.37-0.40
The chart of Sortino ratio for EQH, currently valued at 3.23, compared to the broader market-4.00-2.000.002.004.006.003.23-0.43
The chart of Omega ratio for EQH, currently valued at 1.43, compared to the broader market0.501.001.502.001.430.94
The chart of Calmar ratio for EQH, currently valued at 4.26, compared to the broader market0.002.004.006.004.26-0.32
The chart of Martin ratio for EQH, currently valued at 15.46, compared to the broader market-10.000.0010.0020.0030.0015.46-0.75
EQH
NVS

The current EQH Sharpe Ratio is 2.37, which is higher than the NVS Sharpe Ratio of -0.40. The chart below compares the historical Sharpe Ratios of EQH and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
2.37
-0.40
EQH
NVS

Dividends

EQH vs. NVS - Dividend Comparison

EQH's dividend yield for the trailing twelve months is around 1.82%, less than NVS's 3.87% yield.


TTM20242023202220212020201920182017201620152014
EQH
Equitable Holdings, Inc.
1.82%1.99%2.58%2.72%2.17%2.58%2.34%1.56%0.00%0.00%0.00%0.00%
NVS
Novartis AG
3.87%3.88%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%

Drawdowns

EQH vs. NVS - Drawdown Comparison

The maximum EQH drawdown since its inception was -61.33%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for EQH and NVS. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember20250
-19.32%
EQH
NVS

Volatility

EQH vs. NVS - Volatility Comparison

Equitable Holdings, Inc. (EQH) has a higher volatility of 8.66% compared to Novartis AG (NVS) at 4.22%. This indicates that EQH's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%16.00%AugustSeptemberOctoberNovemberDecember2025
8.66%
4.22%
EQH
NVS

Financials

EQH vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between Equitable Holdings, Inc. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab